Neurocrine Biosciences (NBIX) Tops Q4 EPS by 33c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $156.11 +1.35%
EPS Growth %: -12.4%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -12.4%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of $1.54, $0.33 better than the analyst estimate of $1.21. Revenue for the quarter came in at $515.2 million versus the consensus estimate of $518.2 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Yext, Inc. (YEXT) Tops Q2 EPS by 4c
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
